From January 1, 2024 to March 31, 2024, the company has repurchased 7,553,900 shares, representing 0.64% for CNY 67.18 million. With this, the company has completed the repurchase of 7,829,900 shares, representing 0.66% for CNY 69.72 million under the buyback announced on December 23, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.16 CNY | +3.29% | +9.68% | -12.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.82% | 1.34B | |
+33.83% | 704B | |
+28.59% | 577B | |
-3.24% | 348B | |
+19.07% | 327B | |
+4.71% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.28% | 147B |
- Stock Market
- Equities
- 600267 Stock
- News Zhejiang Hisun Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on December 23, 2023.